Rockefeller Capital Management L.P. Sage Therapeutics, Inc. Transaction History

Rockefeller Capital Management L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$27.52 - $37.99 $495 - $683	-18 Reduced 47.37%	20 $0
Q1 2022 May 13, 2022	BUY	$30.71 - $45.71 $583 - $868	19 Added 100.0%	38 $1,000
Q3 2021 Nov 12, 2021	SELL	$40.26 - $57.37 $22,143 - $31,553	-550 Reduced 96.66%	19 $0
Q2 2021 Aug 10, 2021	BUY	$54.88 - $79.29 $9,274 - $13,400	169 Added 42.25%	569 $32,000
Q1 2021 May 11, 2021	BUY	$70.65 - $96.76 $28,260 - $38,704	400 New	400 $29,000

Q1 2020 May 12, 2020	SELL	$26.15 - $77.24 $65,976 - $194,876	-2,523 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$60.18 - $154.77 $151,834 - $390,484	2,523 New	2,523 $182,000
Q2 2019 Aug 09, 2019	SELL	$157.85 - $183.09 $18,784 - $21,787	-119 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$89.33 - $163.65 $10,630 - $19,474	119 New	119 $19,000

220

52.7M

207K

191K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $730M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.